Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases

P Song, T Ramprasath, H Wang, MH Zou - Cellular and Molecular Life …, 2017 - Springer
Kynurenine pathway (KP) is the primary path of tryptophan (Trp) catabolism in most
mammalian cells. The KP generates several bioactive catabolites, such as kynurenine (Kyn) …

Matrix metalloproteinase in abdominal aortic aneurysm and aortic dissection

EM Maguire, SWA Pearce, R Xiao, AY Oo, Q Xiao - Pharmaceuticals, 2019 - mdpi.com
Abdominal Aortic Aneurysm (AAA) affects 4–5% of men over 65, and Aortic Dissection (AD)
is a life-threatening aortic pathology associated with high morbidity and mortality. Initiators of …

Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans

JB Michel, JL Martin-Ventura, J Egido… - Cardiovascular …, 2011 - academic.oup.com
Aneurysm of the abdominal aorta (AAA) is a particular, specifically localized form of
atherothrombosis, providing a unique human model of this disease. The pathogenesis of …

Pharmacologic management of aneurysms

JH Lindeman, JS Matsumura - Circulation research, 2019 - Am Heart Assoc
Current management of aortic aneurysms relies exclusively on prophylactic operative repair
of larger aneurysms. Great potential exists for successful medical therapy that halts or …

Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …

JHN Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - Am Heart Assoc
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …

Matrix metalloproteinase inhibition therapy for vascular diseases

AC Newby - Vascular pharmacology, 2012 - Elsevier
The matrix metalloproteinases (MMPs) are 23 secreted or cell surface proteases that act
together and with other protease classes to turn over the extracellular matrix, cleave cell …

Cystatin C: an emerging biomarker in cardiovascular disease

C Angelidis, S Deftereos… - Current topics in …, 2013 - ingentaconnect.com
Cystatin C (cys-C) is a small protein molecule (120 amino acid peptide chain, approximately
13kDa) produced by virtually all nucleated cells in the human body. It belongs to the family …

The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human

É Korpos, N Kadri, R Kappelhoff, J Wegner… - Diabetes, 2013 - Am Diabetes Assoc
We provide the first comprehensive analysis of the extracellular matrix (ECM) composition of
peri-islet capsules, composed of the peri-islet basement membrane (BM) and subjacent …

Novel pharmacological approaches in abdominal aortic aneurysm

L Puertas-Umbert, R Almendra-Pegueros… - Clinical …, 2023 - portlandpress.com
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …

Biomarkers of AAA progression. Part 1: extracellular matrix degeneration

FA Hellenthal, WA Buurman, WKWH Wodzig… - Nature Reviews …, 2009 - nature.com
Abdominal aortic aneurysm (AAA) is an important health problem. Elective surgical
treatment is recommended on the basis of an individual's risk of rupture, which is predicted …